Prevalence and Management of Hypertension in MENA Adults in the US

Overview

This study evaluates the prevalence, treatment, and control of hypertension (HTN) among Middle Eastern and North African (MENA) adults in the US, revealing an 18% prevalence rate.

Background

Hypertension is a major risk factor for cardiovascular disease and mortality, yet its epidemiology in the MENA population in the US has been underexplored due to historical misclassification.

Data Highlights

Key Findings

• 18% of MENA adults in the study had hypertension.
• 76% of hypertensive participants were receiving antihypertensive treatment.
• 85% of those treated achieved blood pressure control.
• Participants aged ≤ 50 years had a higher BP control rate compared to those aged >50 years (97% vs. 83%).
• Significant predictors of hypertension included diabetes, chronic kidney disease, and obesity.

Clinical Implications

The study highlights the importance of recognizing hypertension in the MENA population to improve treatment and control rates. Clinicians should consider the unique risk factors present in this demographic when developing management strategies.

Conclusion

The findings indicate that hypertension prevalence among MENA adults in the US is lower than the general population.

Related Resources & Content

1. All of Us Research Program, National Institutes of Health, 2024 -- Prevalence and Management of Hypertension in MENA Adults
2. Journal of General Internal Medicine — Barriers to Medication Adherence and Mild Cognitive Impairment Among African Americans with Persistently Uncontrolled Hypertension: A Cross-sectional Analysis from the Southeastern Collaboration Trial
3. European Journal of Preventive Cardiology — Elevated blood pressure levels among 533 167 adults living in Sub-Saharan Africa: a systematic review and meta-analysis
4. conexiant — US Heart Health Progress Stalls
5. BMC Ophthalmology — Severity of hypertensive retinopathy and its determinants among adult patients attending ophthalmic centers in Northern Ethiopia: A multicenter cross-sectional study
6. Final Recommendation Statement: Hypertension in Adults: Screening | United States Preventive Services Taskforce
7. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension | European Heart Journal
8. The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association - PubMed
9. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
10. https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf
11. A Randomized Trial of Intensive versus Standard Blood-Pressure Control | New England Journal of Medicine
12. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | New England Journal of Medicine
13. current as of September 23, 2008.
14. Chlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events | New England Journal of Medicine
15. Revisions to OMB's Statistical Policy Directive No. 15: Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity, 22182-22196 [2024-06469] :: Management And Budget Office :: Executive Office Of The President :: Regulation Tracker :: Justia
16. All of Us Research Program | National Institutes of Health (NIH)
17. Race and Ethnicity Data Collection and Transformation – User Support
18. Neighborhood Deprivation, Race, Ethnicity, and Undiagnosed Hypertension: Results From the All of Us Research Program - PubMed